Great crunching Mita,
So even with a big hit from generics and no incremental revenue from other products, E in yr 2 is still in the region of 5.6cps and at at current P (45c) gives a PE of 8 times. This is a pretty negative scenario and I expect to be the worst case.
Gives a good yardstick to assess tomorrow's developments, but on the face of it were undervalued in the 40's.
Wazz
Add to My Watchlist
What is My Watchlist?
